News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,835 Results
Type
Article (44629)
Company Profile (264)
Press Release (692928)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (206167)
Career Advice (2099)
Deals (35744)
Drug Delivery (129)
Drug Development (82854)
Employer Resources (175)
FDA (16629)
Job Trends (15152)
News (350038)
Policy (33280)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2670)
Accelerated approval (42)
Adcomms (26)
Allergies (163)
Alliances (49917)
ALS (194)
Alzheimer's disease (1748)
Antibody-drug conjugate (ADC) (372)
Approvals (16933)
Artificial intelligence (598)
Autoimmune disease (225)
Automation (50)
Bankruptcy (364)
Best Places to Work (11772)
BIOSECURE Act (20)
Biosimilars (202)
Biotechnology (174)
Bladder cancer (180)
Brain cancer (66)
Breast cancer (688)
Cancer (5357)
Cardiovascular disease (451)
Career advice (1781)
Career pathing (39)
CAR-T (306)
CDC (60)
Celiac Disease (2)
Cell therapy (811)
Cervical cancer (42)
Clinical research (71260)
Collaboration (1893)
Company closure (4)
Compensation (1270)
Complete response letters (71)
COVID-19 (2775)
CRISPR (100)
C-suite (977)
Cystic fibrosis (149)
Data (7084)
Decentralized trials (3)
Denatured (26)
Depression (156)
Dermatology (57)
Diabetes (557)
Diagnostics (6896)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (293)
Drug pricing (208)
Drug shortages (30)
Duchenne muscular dystrophy (266)
Earnings (91239)
Editorial (64)
Employer branding (22)
Employer resources (154)
Events (120369)
Executive appointments (1035)
FDA (20051)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1619)
Gene editing (216)
Generative AI (51)
Gene therapy (664)
GLP-1 (1046)
Government (4818)
Grass and pollen (6)
Guidances (396)
Healthcare (19300)
HIV (74)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (276)
Immuno-oncology (83)
Indications (157)
Infectious disease (3090)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (130)
Intellectual property (275)
Interviews (325)
IPO (16730)
IRA (50)
Job creations (3697)
Job search strategy (1488)
JPM (58)
Kidney cancer (18)
Labor market (93)
Layoffs (559)
Leadership (34)
Legal (8073)
Liver cancer (98)
Longevity (28)
Lung cancer (718)
Lymphoma (408)
Machine learning (52)
Management (60)
Manufacturing (919)
MASH (178)
Medical device (13942)
Medtech (14019)
Mergers & acquisitions (20171)
Metabolic disorders (1434)
mRNA (177)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (382)
Neuropsychiatric disorders (99)
Neuroscience (3149)
Neurotech (1)
NextGen: Class of 2026 (6662)
Non-profit (4700)
Now hiring (73)
Obesity (678)
Opinion (284)
Ovarian cancer (186)
Pain (229)
Pancreatic cancer (255)
Parkinson's disease (339)
Partnered (33)
Patents (553)
Patient recruitment (589)
Peanut (60)
People (59907)
Pharmaceutical (59)
Pharmacy benefit managers (34)
Phase 1 (22179)
Phase 2 (31326)
Phase 3 (23362)
Pipeline (7113)
Policy (320)
Postmarket research (2698)
Preclinical (9484)
Press Release (65)
Prostate cancer (277)
Psychedelics (49)
Radiopharmaceuticals (307)
Rare diseases (1001)
Real estate (6027)
Recruiting (70)
Regulatory (25292)
Reports (54)
Research institute (2455)
Resumes & cover letters (357)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (269)
Series B (201)
Service/supplier (11)
Sickle cell disease (111)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (45)
Startups (3648)
State (2)
Stomach cancer (19)
Supply chain (117)
Tariffs (89)
The Weekly (65)
Vaccines (1079)
Venture capital (98)
Weight loss (436)
Women's health (109)
Worklife (20)
Date
Last 7 days (642)
Last 30 days (2535)
Last 365 days (30078)
2026 (8023)
2025 (30386)
2024 (35478)
2023 (40363)
2022 (51491)
2021 (56024)
2020 (54583)
2019 (47257)
2018 (35566)
2017 (32476)
2016 (32005)
2015 (38087)
2014 (31879)
2013 (27001)
2012 (29249)
2011 (29917)
2010 (28247)
Location
Africa (765)
Alabama (90)
Alaska (7)
Arizona (332)
Arkansas (13)
Asia (40029)
Australia (6607)
California (12280)
Canada (3511)
China (1240)
Colorado (524)
Connecticut (521)
Delaware (366)
Europe (86887)
Florida (1851)
Georgia (395)
Hawaii (3)
Idaho (62)
Illinois (965)
India (81)
Indiana (559)
Iowa (23)
Japan (485)
Kansas (130)
Kentucky (45)
Louisiana (39)
Maine (73)
Maryland (1493)
Massachusetts (8822)
Michigan (348)
Minnesota (677)
Mississippi (6)
Missouri (139)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (84)
New Jersey (3285)
New Mexico (29)
New York (3244)
North Carolina (1564)
North Dakota (9)
Northern California (6073)
Ohio (365)
Oklahoma (23)
Oregon (41)
Pennsylvania (2486)
Puerto Rico (26)
Rhode Island (51)
South America (1158)
South Carolina (76)
South Dakota (1)
Southern California (4827)
Tennessee (200)
Texas (1932)
United States (43595)
Utah (369)
Vermont (1)
Virginia (292)
Washington D.C. (81)
Washington State (984)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
737,835 Results for "american diagnostica inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company
February 4, 2026
·
1 min read
Press Releases
American Aires Inc. Files Legal Proceedings Against Former Executive
March 13, 2026
·
6 min read
Press Releases
Modular Genetics, Inc. joins New American Industrial Alliance to Reindustrialize America
March 5, 2026
·
1 min read
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
February 16, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 22, 2026
·
5 min read
Press Releases
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 30, 2026
·
10 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026
January 7, 2026
·
3 min read
Press Releases
Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
March 17, 2026
·
8 min read
Press Releases
SignaBlok to Present Novel Approach to Preventing Cancer Recurrence at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Ligand-independent mechanism of action of SignaBlok’s first-in-class TREM-1 inhibitors enables development of cell-unspecific and macrophage-targeted TREM-1 inhibitors · In experimental pancreatic cancer, macrophage-targeted but not cell-unspecific TREM-1 inhibitor: − prevents cancer recurrence, improves complete response rate and survival, when administered in a time window of 7 days after standard-of-care (SOC) chemotherapy − reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy · Timely resolution of acute inflammation induced by SOC cancer treatments (chemotherapy, surgery, radiation, radiopharmaceuticals, etc.) can be a common approach to prevent cancer recurrence, increase response rate and survival for not only pancreatic cancer but also other hard-to-treat tumors
March 26, 2026
·
1 min read
Opinion
Policymakers Must Sustain American Life Sciences Leadership
Maintaining America’s momentum demands that policymakers resist policies that undermine research and development incentives.
February 20, 2026
·
4 min read
·
Dan Leonard
1 of 73,784
Next